Abdel Halim, PharmD, MSc, PhD, DABCC, FAACC

Abdel Halim has a range of experience in the field of biomarkers and diagnostics. Currently, they hold the position of VP, Biomarkers and Companion Diagnostics at TAIHO ONCOLOGY INC. Prior to this, they worked as a Key Opinion Leader for several years. Abdel also served as the VP Translational Medicine, Biomarkers & Diagnostics at Celldex Therapeutics from 2014 to 2018. In the past, Abdel Halim held the position of Global Head, Clinical Biomarkers at Daiichi Sankyo from 2008 to 2013. Abdel has also worked as the Director of Laboratories at LipoScience, where they led efforts to validate NMR plasma lipoprotein technology and managed a team of scientists and technologists. Before that, they worked at Genova Diagnostics, Inc. as an Assistant Director/Technical Manager of Laboratories, overseeing a team of scientists and technologists. Abdel began their career as an Assistant Professor/Associate Director of the Surgical Immunology Lab at the University of Tennessee Health Science Center, where they also worked as a Research Associate. Abdel Halim's expertise includes leading lab operations, developing and validating assays, and ensuring compliance with regulations and guidelines.

Abdel Halim holds a PhD in Biochemistry, focusing on Molecular Biology and Tumor Biomarkers, from Bonn University in Germany and Cairo University in Egypt. Abdel has additional certifications including DABCC-CC (Clinical Chemistry), DABCC-MD (Molecular Diagnostics), DABCC-Tox (Toxicological Chemistry), License as a Clinical Laboratory Director in NY, NJ, TN, PA, MD, and is a Registered Pharmacist in NJ, NY, and NC.